Z-VEID-FMK: Irreversible Caspase-6 Inhibitor for Precision Apoptosis Assays

Executive Summary: Z-VEID-FMK (SKU: A1923) is a fluoromethyl ketone-based, cell-permeable, irreversible caspase-6 inhibitor supplied by APExBIO, enabling precise interrogation of caspase-6-dependent apoptosis pathways (product page). This compound covalently binds the caspase-6 active site, blocking substrate cleavage in neuronal and immune cell models at concentrations of ~50 μM over 6 hours (Zhao et al., 2025). Z-VEID-FMK is validated by HPLC, MS, and NMR with >94% purity, ensuring experimental reproducibility. It is insoluble in water but dissolves in DMSO and ethanol, requiring -20°C storage for optimal stability. Preclinical studies confirm its efficacy in attenuating caspase-6-driven inflammatory responses and microglial activation in vivo (Zhao et al., 2025).

Biological Rationale

Caspase-6 is a cysteine protease classified as an executioner caspase, activated via proteolytic cleavage and dimerization [DOI]. It targets nuclear lamins and other substrates during programmed cell death. Caspase-6 is implicated in the pathophysiology of neurodegenerative diseases, including Alzheimer's and Huntington's disease, by mediating neuronal apoptosis and inflammation [DOI]. Recent evidence links caspase-6 activity to microglial tumor necrosis factor-alpha (TNF-α) secretion, influencing synaptic plasticity and inflammatory pain. Inhibition of caspase-6 allows researchers to dissect cell death pathways distinct from those mediated by caspase-3 or caspase-7 [Strategic Caspase-6 Inhibition]. This article extends the mechanistic focus of Strategic Caspase-6 Inhibition by integrating recent in vivo benchmarks and workflow guidance for translational research.

Mechanism of Action of Z-VEID-FMK

Z-VEID-FMK is a synthetic tetrapeptide (Val-Glu-Ile-Asp) linked to a fluoromethyl ketone (FMK) moiety. The FMK group forms a covalent bond with the active-site cysteine of caspase-6, resulting in irreversible enzyme inactivation [APExBIO]. This direct inhibition prevents cleavage of endogenous substrates, such as nuclear lamins, and downstream signaling events. Z-VEID-FMK is cell-permeable due to its peptide structure and chemical modifications, enabling intracellular delivery without additional carriers. Selectivity for caspase-6 over related caspases is conferred by the VEID sequence, matching the substrate recognition motif of caspase-6 [Advanced Caspase-6 Inhibition]. This article updates the workflow and specificity considerations discussed in Advanced Caspase-6 Inhibition with new in vivo data.

Evidence & Benchmarks

• In a rat inflammatory pain model, intrathecal Z-VEID-FMK (10 μM) significantly reduced microglial activation and TNF-α release, with no effect on Homer1a expression (Zhao et al., 2025).
• Z-VEID-FMK demonstrates >94% purity by HPLC and is validated by mass spectrometry and NMR, supporting experimental reproducibility (APExBIO).
• The compound is insoluble in water but dissolves in DMSO at ≥113.4 mg/mL and in ethanol at ≥3.01 mg/mL, enabling high-concentration stock preparation (APExBIO).
• Typical cell culture applications use 50 μM Z-VEID-FMK with 6-hour incubation for effective caspase-6 inhibition in neuronal cells (Zhao et al., 2025).
• Competitive assays confirm that Z-VEID-FMK selectively inhibits caspase-6 with minimal off-target effects on caspase-3 or caspase-7 (Z-VEID-FMK: Irreversible Caspase-6 Inhibition in Complex Models).

Applications, Limits & Misconceptions

Z-VEID-FMK is widely employed in apoptosis assays, caspase activity measurements, and studies of neurodegenerative and cancer models. It allows functional dissection of the caspase signaling pathway, especially in models where caspase-6 activity is implicated. For example, in vivo application demonstrates attenuation of thermal hypersensitivity in inflammatory pain models via suppression of the caspase-6/TNF-α pathway [Zhao et al., 2025]. The compound is also valuable for distinguishing caspase-6-dependent from caspase-3/7-dependent cell death mechanisms [Strategic Caspase-6 Inhibition with Z-VEID-FMK]; this article clarifies experimental design boundaries beyond those covered in previous workflows.

Common Pitfalls or Misconceptions

• Non-selectivity: Z-VEID-FMK is highly selective for caspase-6, but at high concentrations or prolonged exposure, off-target effects on other caspases may occur (source).
• Solubility Issues: The compound is insoluble in water and requires dissolution in DMSO or ethanol; improper preparation may result in precipitation and loss of activity (APExBIO).
• Storage Conditions: Z-VEID-FMK must be stored at -20°C and protected from repeated freeze-thaw cycles; failure to do so can reduce efficacy (APExBIO).
• Short-term Use: Stock solutions are recommended for short-term use only; long-term storage may compromise inhibitor potency (APExBIO).
• Not effective in caspase-6-independent models: Inhibition will not impact apoptosis or inflammation if caspase-6 is not involved in the pathway (Zhao et al., 2025).

Workflow Integration & Parameters

For experimental use, Z-VEID-FMK should be dissolved in DMSO (≥113.4 mg/mL) or ethanol (≥3.01 mg/mL) with gentle warming and sonication. Prepare aliquots and store at -20°C to minimize freeze-thaw cycles. Apply at final concentrations of 10–50 μM in cell culture; incubate for 6 hours unless protocol optimization suggests otherwise (APExBIO). In animal models, intrathecal or systemic delivery should be guided by prior pharmacokinetic and toxicity assessments. Z-VEID-FMK is compatible with standard apoptosis assays (e.g., TUNEL, caspase activity kits) and can be combined with other pathway inhibitors for mechanistic studies. For additional experimental strategies, see Strategic Caspase-6 Inhibition with Z-VEID-FMK, which this article updates with recent workflow guidance.

Conclusion & Outlook

Z-VEID-FMK constitutes a validated, high-purity, and workflow-friendly tool for dissecting caspase-6-dependent apoptosis and inflammation. Its irreversible, cell-permeable mechanism distinguishes it from reversible or less specific apoptosis inhibitors. The compound's robust characterization and documented in vivo efficacy, as in the attenuation of inflammatory pain, support its ongoing use in translational research (Zhao et al., 2025). For researchers seeking precision in caspase activity measurement and pathway dissection, Z-VEID-FMK from APExBIO offers an optimized solution. For product specifications and ordering, refer to the Z-VEID-FMK product page.